Skip to main content
OpenTrials

Clinical trial condition

Glomerulonephritis, IGA

Explore clinical trials studying Glomerulonephritis, IGA. Study availability and eligibility vary by location and protocol.

190 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Glomerulonephritis, IGA trial results

Completed

Safety and Efficacy Study of VIS649 for IgA Nephropathy

NCT04287985

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations
  • Visterra Investigational Site Birmingham, Alabama, United States
  • Visterra Investigational Site Los Angeles, California, United States
  • Visterra Investigational Site Oxnard, California, United States
  • Visterra Investigational Site Palo Alto, California, United States
View all 93 locations
View Trial Details
Completed

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients

NCT04578834

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • AZ Kidney Dise and Hypertension Ctr Glendale, Arizona, United States
  • AKDHC Medical Research ServicesLLC Phoenix, Arizona, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Kaiser Permanente San Diego, California, United States
View all 177 locations
View Trial Details
Completed

A Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgAN

NCT05856760

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Travere Investigational Site Birmingham, Alabama, United States
  • Travere Investigational Site Chula Vista, California, United States
  • Travere Investigational Site Garden Grove, California, United States
  • Travere Investigational Site Glendale, California, United States
View all 30 locations
View Trial Details
Completed

A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX

NCT03366337

Conditions
Abnormalities, Multiple, Autoimmune Diseases, Autosomal Dominant Polycystic Kidney, +21 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Phoenician Centers for Research & Innovation (PCRI) Phoenix, Arizona, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Denver Nephrology Denver, Colorado, United States
View all 30 locations
View Trial Details

Related conditions